<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
63552-280-00
</NDCCode>
<PackageDescription>
160 SYRINGE in 1 CONTAINER (63552-280-00) / 1 mL in 1 SYRINGE
</PackageDescription>
<NDC11Code>
63552-0280-00
</NDC11Code>
<ProductNDC>
63552-280
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ixekizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20251023
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Patheon Manufacturing Services LLC
</LabelerName>
<SubstanceName>
IXEKIZUMAB
</SubstanceName>
<StrengthNumber>
80
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-10-29
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
23-OCT-25
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>